Gamaleya Research Institute

The Gamaleya Research Institute is a prominent Russian scientific institution located in Moscow, known for its work in microbiology and epidemiology. Established in 1891, it gained international recognition for developing the Sputnik V COVID-19 vaccine, one of the first vaccines authorized for emergency use during the pandemic. The institute focuses on vaccine research, infectious diseases, and public health. Its contributions have made significant impacts on both local and global health initiatives, demonstrating the importance of scientific research in combating diseases and supporting public health efforts.